Dr. Reddy's Laboratories Limited has informed the Exchange that the Annual Report in Form 20F for the fiscal year ended March 31, 2026 has been filed with United States Securities and Exchange Commission.
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Reddy's Laboratories has informed the exchanges that its Annual Report in Form 20-F for the fiscal year ended March 31, 2026 has been filed with the US Securities and Exchange Commission on May 30, 2026. The annual consolidated financial statements are prepared under International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). This is a routine regulatory intimation filed under SEBI Listing Regulations as the company is listed on multiple exchanges including NSE, BSE, NYSE, and NSE IFSC.
This is a standard compliance filing notifying shareholders that the annual report has been filed with US regulators. No immediate impact on stock price; investors can access the full report on the company's website.